Vincent Thomas
Academic contribution (See all users)

By role

By subject area

Academic Editor

Vincent Thomas


Vincent Thomas obtained is PharmD degree in 1999 (Paris XI University). He defended his PhD in the field of microbial ecology (interactions between Legionella pneumophila, biofilms and protozoa) in 2004 in the same University, and then spent 2-years as a post doc at CHUV hospital (Lausanne, Switzerland) to investigate interactions between Free-Living Amoebae and various microorganisms. In 2006, he took a position as a senior researcher at STERIS Corp. to develop a microbiology lab located in the premises of the French Nuclear Agency (CEA, Fontenay-aux-Roses, France) and directed at disinfectant mechanisms of activity against emerging infectious agents including prion, various viruses, protozoa and drug-resistant bacteria. He then left to join the French startup Enterome in 2013. He was specifically in charge of the development and validation of an industrial platform dedicated to DNA extraction, biobanking, metagenomics sequencing and bioinformatic analysis for the analysis of gut microbiota in close association with INRA-Metagenopolis. Vincent joined the Technological Research Institute BIOASTER in 2015 as head of the Biological Collections and Microbiology Unit. He is now head of the Microbiota Program in the same Institute, being specifically in charge of positioning the Institute’s strategy and vision in the field of microbiota research.

Biotechnology Infectious Diseases Microbiology

Work details

Head of Microbiota Program

June 2015
BIOASTER is the only health-related Technology Research Institute (TRI) in France selected by the General Commission for Investments [Commissariat Général à l’Investissement] as part of its Investment for the Future [Programme des Investissements d’Avenir] program. BIOASTER conducts independent and collaborative interdisciplinary R&D activities on the frontier between basic and industrial development to ensure optimal alignment between research and innovation in the fields of infection diseases and microbiology and expand our understanding of intestinal microbiota and its impact on health. As Head of the Microbiota Program, my main tasks consist in • Positioning the Institute’s strategy and vision in the field of microbiota research • Defining key technological developments for BIOASTER's research in this area • Creating relationships with private companies and academics to identify common interests • Developing and executing collaborative R&D projects


PeerJ Contributions

Academic Editor on